vimarsana.com
Home
Live Updates
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights : comparemela.com
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to provide the following corporate...
Related Keywords
Canada ,
Israel ,
Herzliya ,
Tel Aviv ,
United States ,
Canadian ,
Iris Bincovich ,
Chezy Barenholz ,
Innocan Pharma Corporation ,
Bi Sky Global Ltd ,
While The Company ,
Drug Administration ,
Prnewswire Innocan Pharma Corporation ,
Company Or Innocan ,
Pharma Corporation ,
United States Food ,
Fiscal Year ,
Update Link ,
Consumer Wellness ,
Joint Venture ,
Audited Financial Statements ,
Audited Financial ,
Medical Pharmaceuticals ,
Health Care Amp Hospitals ,
Pharmaceuticals ,
Accounting News Amp Issues ,
comparemela.com © 2020. All Rights Reserved.